CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 1, 2012, Pages 222-225

  Lee, Meng Rui ^a,b   Cheng, Aristine ^a   Lee, Yi Chieh ^a   Yang, Ching Yao ^a   Lai, Chih Cheng ^c   Huang, Yu Tsung ^a,c   Ho, Chao Chi ^a   Wang, Hao Chien ^a   Yu, Chong Jen ^a   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Clarithromycin; Erm(41); M.Massiliense

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MINOCYCLINE; MOXIFLOXACIN; RNA 23S; TIGECYCLINE; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL STRAIN; BACTERIUM ISOLATE; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DEVICE REMOVAL; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; NEUROSURGERY; NUCLEOTIDE SEQUENCE; OTORHINOLARYNGOLOGY; POLYMERASE CHAIN REACTION; RISK FACTOR; SURVIVAL RATE; TREATMENT DURATION; UNIVERSITY HOSPITAL; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MYCOBACTERIOSIS; PATHOLOGY; SURVIVAL; TAIWAN;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; SURVIVAL ANALYSIS; TAIWAN; YOUNG ADULT;

EID: 84859177589     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr420     Document Type: Article

References (10)

1. Flor A, Capdevila JA, Martin N et al. Nontuberculous mycobacterial meningitis: report of two cases and review. Clin Infect Dis 1996; 23:1266-73.
2. Talati NJ, Rouphael N, Kuppalli K et al. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis 2008; 8:390-8.
3. Little AA, Gebarski SS, Blaivas M. Nontuberculous mycobacterial infection of a metastatic brain neoplasm in an immunocompromised patient. Arch Neurol 2006; 63: 763-5.
4. Maniu CV, Hellinger WC, Chu SY et al. Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid. Clin Infect Dis 2001; 33: 745-8.
5. Liebeskind DS, Ostrzega N,Wasterlain CG et al. Neurologicmanifestations of disseminated infection with Mycobacterium abscessus. Neurology 2001;56: 810-3.
6. Koh WJ Jeon K, Lee NY et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011; 183: 405-10.
7. Nash KA, Brown-Elliott BA,Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 2009; 53: 1367-76.
8. Kim HY, Kim BJ, Kook Y et al. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol Immunol 2010; 54:347-53.
9. Lai CC, Tan CK, Chou CH et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis 2010; 16: 294-6.
10. Duarte RS, Lourenco MC, Fonseca Lde S et al. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J Clin Microbiol 2009;47: 2149-55.